Category: Business and Investments
Healthcare reform: sustaining biotech innovation in a new world
The Eighth Annual BIO Investor Forum kicked off today with a plenary session on health …
Guest blogger post: The Lure of Translational Research
As a breast cancer advocate, I am seduced by the lure of translational research and …
The Burrill Report Interview with Jim Greenwood
The Burrill Report’s Daniel Levine spoke with Jim Greenwood, president and CEO of BIO, about …
Development continues for osteoporosis drug
Osteologix, Inc. (OLGX.OB) will continue the clinical development for its osteoporosis drug, NB S101 (strontium …
Oncolytics invests in private biotech company
Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) invested in British Canadian Biosciences Corp., a privately …
Podcast with Fast Forward's Tim Coetzee
Biotech Now’s Tracy Krughoff spoke with Dr. Tim Coetzee, president of Fast Forward, a subsidiary …
Q&A with Complete Genomics' Dr. Clifford Reid
Read a recent interview with Complete Genomics Chairman, President, and CEO Clifford Reid about his …
A BIO Investor Forum Success Story
A year ago, CombinatoRx probably wouldn’t have guessed a multi-million dollar merger was on the …
Podcast with Debra Miller, Cure Duchenne
Biotech-Now’s Tracy Krughoff spoke with Cure Duchenne’s President, Debra Miller. Cure Duchenne will be one …
Novavax launches study of novel H1N1 vaccine in Mexico
Novavax, Inc. (Nasdaq: NVAX) initiated a two-stage clinical study of its virus-like-particle (VLP) H1N1 influenza …